Oct-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
The Tablet has maintained a consistent presence in the Capsules category in California, holding steady at the 7th position from July to October 2025. This stability in ranking suggests a solid foothold within the market, indicating that the brand has a loyal customer base or effective distribution channels in the state. Interestingly, despite a slight dip in sales from August to September, The Tablet managed to recover in October, highlighting resilience in its market performance. This steady ranking amidst fluctuating sales figures might suggest strategic pricing or promotional efforts that kept the brand's visibility and appeal intact.
While The Tablet's consistent ranking in California's Capsules category is commendable, it is noteworthy that it does not appear in the top 30 brands for any other states or categories during the same period. This absence could imply either a strategic focus on the California market or challenges in penetrating other markets. The lack of presence outside California might be seen as a potential area for growth or a reflection of competitive pressures in other states. This situation presents an interesting dynamic where The Tablet could explore expansion opportunities or enhance its market strategies to diversify its reach beyond California.
Competitive Landscape
In the competitive landscape of the California capsules market, The Tablet has maintained a steady position at rank 7 from July to October 2025. This consistency in ranking suggests a stable market presence, though it faces stiff competition from brands like Buddies and Emerald Bay Extracts, which have consistently ranked higher, occupying the 5th and 6th positions respectively. Despite this, The Tablet's sales figures have shown resilience, with a slight increase from $130,909 in July to $132,526 in October, indicating a positive trend in consumer acceptance. Meanwhile, Papa & Barkley and Proof have maintained lower ranks at 9th and 10th, respectively, suggesting that The Tablet is effectively positioned in the mid-tier of the market. The stability in The Tablet's ranking amidst fluctuating sales figures of competitors highlights its potential for growth if strategic marketing efforts are enhanced.

Notable Products
In October 2025, the top-performing product from The Tablet was Sativa High Dose Tablets 50-Pack (1000mg) in the Capsules category, maintaining its number one rank from September despite a slight decrease in sales to 903 units. Following closely, Sativa Tablets 20-Pack (1000mg) held the second position, a consistent spot from the previous month, with notable sales of 886 units. The Indica Tablets 20-Pack (1000mg) secured the third rank, showing an improvement from its fourth-place position in September with sales increasing to 787 units. Indica High Dose Tablets 50-Pack (1000mg) remained steady at the fourth rank, experiencing a minor drop in sales compared to the previous month. Overall, the rankings for The Tablet's top products were relatively stable, with slight changes in sales figures across the board.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.







